Teva Completes Enrollment in Laquinimod Phase III Clinical Trial
- Press Release
- Source: Active Biotech
- On 2:09 am EST, Tuesday November 18, 2008
LUND, SWEDEN--(MARKET WIRE)--Nov 18, 2008 --
- Recruitment Still Ongoing For Second, Pivotal Phase III
Study,
Bravo -
Related Quotes
| |||||||||
Jerusalem, Israel and Lund, Sweden, November 18, 2008 - Teva Pharmaceutical Industries Ltd. (NasdaqGS:TEVA - News) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced completion of patient enrollment for the Phase III clinical trial, Allegro, in relapsing-remitting multiple sclerosis (RRMS). The pivotal Allegro study is designed to evaluate the efficacy, safety and tolerability of the oral investigational compound, laquinimod, versus placebo in the treatment of RRMS.
Active Biotech is obligated to publish the information contained in this press release in accordance with the Swedish Securities Market Act. This information was provided to the media for publication on November 18, 2008, at 8:00 a.m.
Contact: Elana Holzman, Teva Pharmaceutical Industries Ltd., +972 3 926-7554 Kevin Mannix, Teva North America, +1 215 591-8912 Tomas Leanderson, Active Biotech AB, +46 46 19 20 95 Göran Forsberg, Active Biotech AB, +46 46 19 11 54
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial: http://hugin.info/1002/R/1270575/281461.pdf
Copyright © Hugin AS 2008. All rights reserved.
Contact:
Related Headlines
- Q3 2009 Active Biotech AB Earnings Release - Time Not Supplied - CCBN
- Active Biotech's election committee appointed - Marketwire
- Active Biotech AB Interim Report, January - September 2009 - Marketwire
- RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities - Marketwire
- Active Biotech to Present at the UBS Global Life Sciences Conference - Marketwire
Sponsored Links
-
Trade Stocks? Try Currency Trading
Trade in a highly trending market 24-hrs a day, 5.5 days a week. GFT. -
2.00-2.30% Apply Online
From AA+ Rated GE Capital Corp. Not An Offer Of Securities For Sale.
-
Super Cheap Car Insurance Quotes
Get Discount Auto Insurance Quotes Online - Rates from $15 / Month. -
Buy Stocks - $4 Fee at ShareBuilder
No account or investment minimums. No inactivity fees. Start today.
Tech Ticker Recent Posts
- China's Premier Warns Obama to Get America's Deficit to an "Appropriate Size" - Heesun Wee
- Partying Like It's 1983 - Henry Blodget
- Immunized for Swine Flu, Goldman's CEO Catches Foot-in-Mouth Disease - Aaron Task
Add Alert Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.